Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · IEX Real-Time Price · USD
13.01
-0.30 (-2.29%)
Apr 25, 2024, 10:13 AM EDT - Market open
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ELAN stock have an average target of 16.29, with a low estimate of 9.00 and a high estimate of 20. The average target predicts an increase of 25.26% from the current stock price of 13.01.
Analyst Consensus: Hold
* Price targets were last updated on Mar 12, 2024.
Analyst Ratings
The average analyst rating for ELAN stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $12 → $18 | Hold | Reiterates | $12 → $18 | +38.41% | Mar 12, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $13 → $14 | Strong Sell | Maintains | $13 → $14 | +7.65% | Feb 27, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $16 → $17 | Buy | Maintains | $16 → $17 | +30.72% | Feb 27, 2024 |
| Barclays | Barclays | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +46.10% | Feb 27, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $10 → $13 | Strong Sell | Maintains | $10 → $13 | -3.88% | Jan 17, 2024 |
Financial Forecast
Revenue This Year
4.59B
from 4.42B
Increased by 3.85%
Revenue Next Year
4.77B
from 4.59B
Increased by 3.90%
EPS This Year
0.94
from -2.50
EPS Next Year
1.08
from 0.94
Increased by 15.43%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.8B | 5.0B | 5.2B | 5.4B | 5.6B |
| Avg | 4.6B | 4.8B | 5.0B | 5.2B | 5.4B |
| Low | 4.4B | 4.4B | 4.6B | 5.0B | 5.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.8% | 8.9% | 9.2% | 8.9% | 6.5% |
| Avg | 3.8% | 3.9% | 4.1% | 5.8% | 3.5% |
| Low | -1.2% | -3.4% | -3.3% | 1.6% | -0.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.02 | 1.20 | 1.31 | 1.31 | 1.47 |
| Avg | 0.94 | 1.08 | 1.19 | 1.28 | 1.43 |
| Low | 0.86 | 0.94 | 1.07 | 1.23 | 1.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 27.8% | 21.4% | 10.5% | 15.3% |
| Avg | - | 15.4% | 9.9% | 7.3% | 12.0% |
| Low | - | 0.4% | -1.2% | 3.1% | 7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.